Form 4 for OMCL OMNICELL, INC.
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-07 · accession 0001415889-23-004581 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-09 | 2023-03-07 | OMCL | Bauer Joanne B | Dir | S - Sale+OE | $54.24 | -13.1K | 31.4K | -29% | -$711.4K |
| D | 2023-03-09 | 2023-03-07 | OMCL | Bauer Joanne B | Dir | M - OptEx | $25.53 | +19.3K | 41.2K | +88% | +$493.5K |
| D | 2023-03-09 | 2023-03-07 | OMCL | Bauer Joanne B | Dir | M - OptEx | $0.00 | -19.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-07 | S | D | 3,318 | $55.04 | 28,096 | D | — | — | (F1) The shares sold and reported on this Form 4 were sold to cover the exercise price and the reporting person's estimated tax liability. (F3) The price reported in Column 4 is a weighted average price of $55.0377. The sold price range between $54.60 to $55.3350. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-03-07 | M | A | 19,329 | $25.53 | 41,211 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-07 | S | D | 9,797 | $53.97 | 31,414 | D | — | — | (F2) The price reported in Column 4 is a weighted average price of $53.9673. The sold price range between $53.60 to $54.52. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F1) The shares sold and reported on this Form 4 were sold to cover the exercise price and the reporting person's estimated tax liability. |
| 4 | Derivative | Stock Option NQ (Right to Buy) | 2023-03-07 | M | D | 19,329 | $0.00 | 0 | D | $25.53 · 2018-01-01 to 2023-12-31 | 19,329 Common Stock |